Extracellular vesicles and their role in glioblastoma

References

• Pan B-T, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33(3):967–978.
   PubMed Web of Science ®Google Scholar
• Emanueli C, Shearn AIU, Angelini GD, et al. Exosomes and exosomal miRNAs in cardiovascular protection and repair. Vascul Pharmacol. 2015;71:24–30.
   PubMed Web of Science ®Google Scholar
• Sahoo S, Losordo DW. Exosomes and cardiac repair after myocardial infarction. Circ Res. 2014;114(2):333–344.
   PubMed Web of Science ®Google Scholar
• Tannetta D, Dragovic R, Alyahyaei Z, et al. Extracellular vesicles and reproduction–promotion of successful pregnancy. Cell Mol Immunol. 2014;11:548.
   PubMed Web of Science ®Google Scholar
• Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013;32(3–4):623–642.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yuan X, Shi H, et al. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015;8:83.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659.
   PubMed Web of Science ®Google Scholar
• Josson S, Gururajan M, Sung SY, et al. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene. 2015;34(21):2690.
   PubMed Web of Science ®Google Scholar
• Tadokoro H, Umezu T, Ohyashiki K, et al. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013;288(48):34343–34351.
   PubMed Web of Science ®Google Scholar
• Chen W-x, Liu X-m, Lv M-m, et al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One. 2014;9(4):e95240.
   PubMed Web of Science ®Google Scholar
• Corcoran C, Rani S, O’Brien K, et al. Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One. 2012;7(12):e50999.
   PubMed Web of Science ®Google Scholar
• Lv M-m, Zhu X-y, Chen W-x, et al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumor Biol. 2014;35(11):10773–10779.
   PubMedGoogle Scholar
• Chiarugi P, Cirri P. Metabolic exchanges within tumor microenvironment. Cancer Lett. 2016;380(1):272–280.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Gittleman H, Truitt G, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-Oncology. 2018;20(suppl_4):iv1–iv86.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996.
   PubMed Web of Science ®Google Scholar
• Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19(2):43–51.
   PubMed Web of Science ®Google Scholar
• Akers JC, Gonda D, Kim R, et al. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113(1):1–11.
   PubMed Web of Science ®Google Scholar
• Hugel B, Martínez MC, Kunzelmann C, et al. Membrane microparticles: two sides of the coin. Physiology. 2005;20(1):22–27.
   PubMedGoogle Scholar
• Graner MW. Brain tumor exosomes and microvesicles: pleiotropic effects from tiny cellular surrogates. Molecular targets of CNS tumors. London (UK): IntechOpen; 2011.
   Google Scholar
• Edgar JR, Eden ER, Futter CE. Hrs‐and CD63‐dependent competing mechanisms make different sized endosomal intraluminal vesicles. Traffic. 2014;15(2):197–211.
   PubMed Web of Science ®Google Scholar
• Henne WM, Stenmark H, Emr SD. Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb Perspect Biol. 2013;5(9):a016766.
   PubMed Web of Science ®Google Scholar
• Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013;126:5553–5565.
   PubMed Web of Science ®Google Scholar
• Hurley JH, Hanson PI. Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol. 2010;11(8):556–566.
   PubMed Web of Science ®Google Scholar
• Hurley JH. ESCRTs are everywhere. Embo J. 2015;34(19):2398–2407.
   PubMed Web of Science ®Google Scholar
• Nabhan JF, Hu R, Oh RS, et al. Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc Natl Acad Sci. 2012;109(11):4146–4151.
   PubMed Web of Science ®Google Scholar
• Wehman Ann M, Poggioli C, Schweinsberg P, et al. The P4-ATPase TAT-5 inhibits the budding of extracellular vesicles in C. elegans embryos. Curr Biol. 2011;21(23):1951–1959.
   PubMed Web of Science ®Google Scholar
• Stuffers S, Sem Wegner C, Stenmark H, et al. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic. 2009;10(7):925–937.
   PubMed Web of Science ®Google Scholar
• Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244–1247.
   PubMed Web of Science ®Google Scholar
• Bianco F, Perrotta C, Novellino L, et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. Embo J. 2009;28(8):1043–1054.
   PubMed Web of Science ®Google Scholar
• Antonucci F, Turola E, Riganti L, et al. Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO J. 2012;31(5):1231–1240.
   PubMed Web of Science ®Google Scholar
• Tisdale EJ. Glyceraldehyde-3-phosphate dehydrogenase is required for vesicular transport in the early secretory pathway. J Biol Chem. 2001;276(4):2480–2486.
   PubMed Web of Science ®Google Scholar
• Zhang H, Freitas D, Kim HS, et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol. 2018;20(3):332–343.
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
   PubMed Web of Science ®Google Scholar
• Gardiner C, Vizio DD, Sahoo S, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5(1):32945.
   PubMed Web of Science ®Google Scholar
• Thery C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;30(1):3.22.1–3.22.29.
   Google Scholar
• Lamparski HG, Metha-Damani A, Yao J-Y, et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods. 2002;270:211–226.
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Balaj L, Alian S, et al. Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front Physiol. 2012;3:162
   PubMed Web of Science ®Google Scholar
• Cantin R, Diou J, Bélanger D, et al. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J Immunol Methods. 2008;338:21–30.
   PubMed Web of Science ®Google Scholar
• Li P, Kaslan M, Lee SH, et al. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789–804.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015;219:396–405.
   PubMed Web of Science ®Google Scholar
• Zeringer E, Barta T, Li M, et al. Strategies for isolation of exosomes. Cold Spring Harb Protoc. 2015;2015(4):pdb.top074476–323.
   Google Scholar
• Gámez-Valero A, Monguió-Tortajada M, Carreras-Planella L, et al. Size-exclusion chromatography-based isolation minimally alters extracellular vesicles’ characteristics compared to precipitating agents. Sci Rep. 2016;6(1):33641.
   PubMedGoogle Scholar
• Szatanek R, Baran J, Siedlar M, et al. Isolation of extracellular vesicles: determining the correct approach. Int J Mol Med. 2015;36:11–17.
   PubMed Web of Science ®Google Scholar
• Yamada T, Inoshima Y, Matsuda T, et al. Comparison of methods for isolating exosomes from bovine milk. J Vet Med Sci. 2012. 74(11):1523–1525.
   PubMed Web of Science ®Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19.
   PubMed Web of Science ®Google Scholar
• Desnos C, Schonn J-S, Huet S, et al. Rab27A and its effector MyRIP link secretory granules to F-actin and control their motion towards release sites. J Cell Biol. 2003;163(3):559–570.
   PubMed Web of Science ®Google Scholar
• Mizuno K, Tolmachova T, Ushakov DS, et al. Rab27b regulates mast cell granule dynamics and secretion. Traffic. 2007;8(7):883–892.
   PubMed Web of Science ®Google Scholar
• Savina A, Vidal M, Colombo MI. The exosome pathway in K562 cells is regulated by Rab11. J Cell Sci. 2002;115(Pt 12):2505–2515.
   PubMed Web of Science ®Google Scholar
• Korkut C, Li Y, Koles K, et al. Regulation of postsynaptic retrograde signaling by presynaptic exosome release. Neuron. 2013;77(6):1039–1046.
   PubMed Web of Science ®Google Scholar
• Hsu C, Morohashi Y, Yoshimura S-i, et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A–C. J Cell Biol. 2010;189(2):223–232.
   PubMed Web of Science ®Google Scholar
• Sato M, Sato K, Liou W, et al. Regulation of endocytic recycling by C. elegans Rab35 and its regulator RME-4, a coated-pit protein. Embo J. 2008;27(8):1183–1196.
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Wang R-A, Talukder AH, et al. Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells. Mol Cell Biol. 2000;20(23):9092–9101.
   PubMed Web of Science ®Google Scholar
• Madison DL, KruGer WH, Kim T, et al. Differential expression of rab3 isoforms in oligodendrocytes and astrocytes. J Neurosci Res. 1996;45(3):258–268.
   PubMed Web of Science ®Google Scholar
• Rao SK, Huynh C, Proux-Gillardeaux V, et al. Identification of SNAREs involved in synaptotagmin VII-regulated lysosomal exocytosis. J Biol Chem. 2004;279(19):20471–20479.
   PubMed Web of Science ®Google Scholar
• Gross J, Chaudhary V, Bartscherer K, et al. Active Wnt proteins are secreted on exosomes. Nat Cell Biol. 2012;14(10):1036–1045.
   PubMed Web of Science ®Google Scholar
• Pelham HR. SNAREs and the specificity of membrane fusion. Trends Cell Biol. 2001;11(3):99–101.
   PubMed Web of Science ®Google Scholar
• Jahn R, Fasshauer D. Molecular machines governing exocytosis of synaptic vesicles. Nature. 2012;490(7419):201–207.
   PubMed Web of Science ®Google Scholar
• Koles K, Nunnari J, Korkut C, et al. Mechanism of evenness interrupted (Evi)-exosome release at synaptic boutons. J Biol Chem. 2012;287(20):16820–16834.
   PubMed Web of Science ®Google Scholar
• Ulloa F, Gonzàlez-Juncà A, Meffre D, et al. Blockade of the SNARE protein syntaxin 1 inhibits glioblastoma tumor growth. PLoS One. 2015;10(3):e0119707-e0119707.
   Web of Science ®Google Scholar
• Mittelbrunn M, Vicente‐Manzanares M, Sánchez‐Madrid F. Organizing polarized delivery of exosomes at synapses. Traffic. 2015;16(4):327–337.
   PubMed Web of Science ®Google Scholar
• Granger E, McNee G, Allan V, et al. The role of the cytoskeleton and molecular motors in endosomal dynamics. Semin Cell Dev Biol. 2014;31:20–29.
   PubMed Web of Science ®Google Scholar
• Sinha S, Hoshino D, Hong NH, et al. Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol. 2016;214(2):197–213.
   PubMed Web of Science ®Google Scholar
• Li B, Antonyak MA, Zhang J, et al. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene. 2012;31(45):4740.
   PubMed Web of Science ®Google Scholar
• Gasser O, Schifferli JA. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood. 2004;104(8):2543–2548.
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10):1907–1920.
   PubMed Web of Science ®Google Scholar
• Berenguer J, Lagerweij T, Zhao XW, et al. Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8. J Extracell Vesicles. 2018;7(1):1446660.
   PubMed Web of Science ®Google Scholar
• Gasser O, Hess C, Miot S, et al. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res. 2003;285(2):243–257.
   PubMed Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen T-L, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329.
   PubMed Web of Science ®Google Scholar
• Christianson HC, Svensson KJ, van Kuppevelt TH, et al. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci U S A. 2013;110(43):17380–17385.
   PubMed Web of Science ®Google Scholar
• Feng D, Zhao WL, Ye YY, et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 2010;11(5):675–687.
   PubMed Web of Science ®Google Scholar
• Svensson KJ, Christianson HC, Wittrup A, et al. Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem. 2013;288(24):17713–17724.
   PubMed Web of Science ®Google Scholar
• Atai N, Balaj L, van Veen H, et al. Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J Neurooncol. 2013;115(3):343–351.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2018;68:7–30.
   PubMed Web of Science ®Google Scholar
• Skog J, Würdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470–1476.
   PubMed Web of Science ®Google Scholar
• Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008;10(5):619.
   PubMed Web of Science ®Google Scholar
• Setti M, Osti D, Richichi C, et al. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth. Oncotarget. 2015;6(31):31413
   PubMedGoogle Scholar
• Arscott WT, Tandle AT, Zhao S, et al. Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. Trans Oncol. 2013;6(6):638–648.
   PubMed Web of Science ®Google Scholar
• Svensson KJ, Kucharzewska P, Christianson HC, et al. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2–mediated heparin-binding EGF signaling in endothelial cells. Proc Natl Acad Sci Usa. 2011;108(32):13147–13152.
   PubMed Web of Science ®Google Scholar
• Kucharzewska P, Christianson HC, Welch JE, et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci. 2013;110(18):7312–7317.
   PubMed Web of Science ®Google Scholar
• van der Vos KE, Abels ER, Zhang X, et al. Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain. Neuro Oncol. 2016;18(1):58–69.
   PubMed Web of Science ®Google Scholar
• Auffinger B, Spencer D, Pytel P, et al. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother. 2015;15:741–752.
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396.
   PubMed Web of Science ®Google Scholar
• Ricklefs F, Mineo M, Rooj AK, et al. Extracellular vesicles from high-grade glioma exchange diverse pro-oncogenic signals that maintain intratumoral heterogeneity. Cancer Res. 2016;76:2876–2881.
   PubMed Web of Science ®Google Scholar
• Garnier D, Magnus N, Meehan B, et al. Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Exp Cell Res. 2013;319:2747–2757.
   PubMed Web of Science ®Google Scholar
• Treps L, Perret R, Edmond S, et al. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles. J Extracell Vesicles. 2017;6(1):1359479.
   PubMed Web of Science ®Google Scholar
• Lang H-L, Hu G-W, Zhang B, et al. Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2. Oncol Rep. 2017;38(2):785–798.
   PubMed Web of Science ®Google Scholar
• Sun X, Ma X, Wang J, et al. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal. Oncotarget. 2017;8:36137.
   PubMedGoogle Scholar
• Redzic JS, Ung TH, Graner MW. Glioblastoma extracellular vesicles: reservoirs of potential biomarkers. Pharmacogenomics Pers Med. 2014;7:65–77.
   PubMedGoogle Scholar
• Graner MW, Alzate O, Dechkovskaia AM, et al. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 2009;23(5):1541–1557.
   PubMed Web of Science ®Google Scholar
• Li CCY, Eaton SA, Young PE, et al. Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol. 2013;10(8):1333–1344.
   PubMed Web of Science ®Google Scholar
• Batagov AO, Kurochkin IV. Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3′-untranslated regions. Biol Direct. 2013;8(1):12.
   PubMedGoogle Scholar
• Zomer A, Vendrig T, Hopmans E, et al. Exosomes. Commun Integr Biol. 2010;3:447–450.
   PubMedGoogle Scholar
• Frederick L, Wang X-Y, Eley G, et al. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res. 2000;60:1383–1387.
   PubMed Web of Science ®Google Scholar
• Gan HK, Kaye AH, Luwor RB. The EGFRvIII variant in glioblastoma multiforme. J Clin Neurosci. 2009;16(6):748–754.
   PubMed Web of Science ®Google Scholar
• Choi D, Montermini L, Kim D-K, et al. The impact of oncogenic EGFRvIII on the proteome of extracellular vesicles released from glioblastoma cells. Mol Cell Proteomics. 2018;17:1948–1964.
   PubMed Web of Science ®Google Scholar
• Kore RA, Edmondson JL, Jenkins SV, et al. Hypoxia-derived exosomes induce putative altered pathways in biosynthesis and ion regulatory channels in glioblastoma cells. Biochem Biophys Rep. 2018;14:104–113.
   PubMedGoogle Scholar
• Graner MW, Cumming RI, Bigner DD. The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequences. J Neurosci. 2007;27(42):11214–11227.
   PubMed Web of Science ®Google Scholar
• de Vrij J, Maas SN, Kwappenberg KM, et al. Glioblastoma‐derived extracellular vesicles modify the phenotype of monocytic cells. Int J Cancer. 2015;137(7):1630–1642.
   PubMed Web of Science ®Google Scholar
• Ricklefs FL, Alayo Q, Krenzlin H, et al. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci Adv. 2018;4(3):eaar2766.
   PubMed Web of Science ®Google Scholar
• Domenis R, Cesselli D, Toffoletto B, et al. Systemic T cells immunosuppression of glioma stem cell-derived exosomes is mediated by monocytic myeloid-derived suppressor cells. PLoS One. 2017;12(1):e0169932.
   PubMed Web of Science ®Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65(14):6029–6033.
   PubMed Web of Science ®Google Scholar
• Godlewski J, Nowicki MO, Bronisz A, et al. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell. 2010;37(5):620–632.
   PubMed Web of Science ®Google Scholar
• Jiang L, Lin C, Song L, et al. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop. J Clin Invest. 2012;122(1):33–47.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang S, Yao J, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527(7576):100–104.
   PubMed Web of Science ®Google Scholar
• Camacho L, Guerrero P, Marchetti D. MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. PLoS One. 2013;8(9):e73790.
   PubMed Web of Science ®Google Scholar
• Villarroya-Beltri C, Gutiérrez-Vázquez C, Sánchez-Cabo F, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4(1):2980.
   PubMed Web of Science ®Google Scholar
• Koppers-Lalic D, Hackenberg M, Bijnsdorp IV, et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 2014;8(6):1649–1658.
   PubMed Web of Science ®Google Scholar
• Nanegrungsunk D, Onchan W, Chattipakorn N, et al. Current evidence of temozolomide and bevacizumab in treatment of gliomas. Neurol Res. 2015;37(2):167–183.
   PubMed Web of Science ®Google Scholar
• Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997–1003.
   PubMed Web of Science ®Google Scholar
• Lawrence M, Stojanov P, Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214–218.
   PubMed Web of Science ®Google Scholar
• Franceschi E, Minichillo S, Brandes AA. Pharmacotherapy of glioblastoma: established treatments and emerging concepts. CNS Drugs. 2017;31(8):675–684.
   PubMed Web of Science ®Google Scholar
• Zhao M, Xu J, Zhong S, et al. Expression profiles and potential functions of circular RNAs in extracellular vesicles isolated from radioresistant glioma cells. Oncol Rep. 2019;41:1893–1900.
   PubMed Web of Science ®Google Scholar
• André-Grégoire G, Bidère N, Gavard J. Temozolomide affects extracellular vesicles released by glioblastoma cells. Biochimie. 2018;155:11–15.
   PubMed Web of Science ®Google Scholar
• Zeng A, Wei Z, Yan W, et al. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Cancer Lett. 2018;436:10–21.
   PubMed Web of Science ®Google Scholar
• Safaei R, Larson BJ, Cheng TC, et al. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther. 2005;4(10):1595–1604.
   PubMed Web of Science ®Google Scholar
• Federici C, Petrucci F, Caimi S, et al. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS One. 2014;9(2):e88193.
   PubMed Web of Science ®Google Scholar
• Simon T, Pinioti S, Schellenberger P, et al. Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma. Mol Cancer. 2018;17(1):132–132.
   PubMedGoogle Scholar
• Bianco J, Bastiancich C, Jankovski A, et al. On glioblastoma and the search for a cure: where do we stand? Cell Mol Life Sci. 2017;74(13):2451–2466.
   PubMed Web of Science ®Google Scholar
• Hess CF, Schaaf JC, Kortmann RD, et al. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol. 1994;30(2):146–149.
   PubMed Web of Science ®Google Scholar
• Demuth T, Berens M. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol. 2004;70(2):217–228.
   PubMed Web of Science ®Google Scholar
• Kelly T, Yan Y, Osborne RL, et al. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin Exp Metastasis. 1998;16(6):501–512.
   PubMed Web of Science ®Google Scholar
• Mader CC, Oser M, Magalhaes MAO, et al. An EGFR–Src–Arg–Cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res. 2011;71(5):1730–1741.
   PubMed Web of Science ®Google Scholar
• Coopman PJ, Do MT, Thompson EW, et al. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res. 1998;4(2):507–515.
   PubMed Web of Science ®Google Scholar
• Monsky WL, Lin CY, Aoyama A, et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 1994;54(21):5702–5710.
   PubMed Web of Science ®Google Scholar
• Clark ES, Whigham AS, Yarbrough WG, et al. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 2007;67(9):4227–4235.
   PubMed Web of Science ®Google Scholar
• Hayes KE, Walk EL, Ammer AG, et al. Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop. Oncogene. 2013;32(40):4766–4777.
   PubMed Web of Science ®Google Scholar
• Schoumacher M, Goldman RD, Louvard D, et al. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol. 2010;189(3):541–556.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H. Pathological roles of invadopodia in cancer invasion and metastasis. Eur J Cell Biol. 2012;91(11–12):902–907.
   PubMed Web of Science ®Google Scholar
• Gligorijevic B, Wyckoff J, Yamaguchi H, et al. N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci. 2012;125(3):724–734.
   PubMed Web of Science ®Google Scholar
• Sutoh M, Hashimoto Y, Yoneyama T, et al. Invadopodia formation by bladder tumor cells. Oncol Res. 2010;19(2):85–92.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Sutoh M, Hatakeyama S, et al. Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells. J Urol. 2011;185(5):1930–1938.
   PubMed Web of Science ®Google Scholar
• Takkunen M, Hukkanen M, Liljeström M, et al. Podosome-like structures of non-invasive carcinoma cells are replaced in epithelial-mesenchymal transition by actin comet-embedded invadopodia. J Cell Mol Med. 2009;14(6b):1569–1593.
   PubMed Web of Science ®Google Scholar
• Stylli S, Kaye A, Lock P. Invadopodia: at the cutting edge of tumour invasion. J Clin Neurosci. 2008;15(7):725–737.
   PubMed Web of Science ®Google Scholar
• Hoshino D, Kirkbride KC, Costello K, et al. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep. 2013;5(5):1159.
   PubMed Web of Science ®Google Scholar
• Schlienger S, Campbell S, Claing A. ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion. Mol Biol Cell. 2014;25(1):17–29.
   PubMed Web of Science ®Google Scholar
• Hallal S, Mallawaaratchy D, Wei H, et al. Extracellular vesicles released by glioblastoma cells stimulate normal astrocytes to acquire a tumor-supportive phenotype via p53 and MYC signaling pathways. Mol Neurobiol. 2018;56(6):4566–4581.
   PubMed Web of Science ®Google Scholar
• Mao L, Whitehead CA, Paradiso L, et al. Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide. J Neurosurg. 2017;129(3):598–610.
   PubMed Web of Science ®Google Scholar
• Whitehead CA, Nguyen HP, Morokoff AP, et al. Inhibition of radiation and temozolomide-induced invadopodia activity in glioma cells using FDA-approved drugs. Transl Oncol. 2018;11(6):1406–1418.
   PubMed Web of Science ®Google Scholar
• Beghein E, Devriese D, Van Hoey E, et al. Cortactin and fascin-1 regulate extracellular vesicle release by controlling endosomal trafficking or invadopodia formation and function. Sci Rep. 2018;8(1):15606–15606.
   PubMedGoogle Scholar
• Havrylov S, Park M. MS/MS-based strategies for proteomic profiling of invasive cell structures. Proteomics. 2015;15(2–3):272–286.
   PubMed Web of Science ®Google Scholar
• Mallawaaratchy DM, Hallal S, Russell B, et al. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. J Neurooncol. 2017;131(2):233–244.
   PubMed Web of Science ®Google Scholar
• Shimoda M, Khokha R. Proteolytic factors in exosomes. Proteomics. 2013;13(10–11):1624–1636.
   PubMed Web of Science ®Google Scholar
• Hakulinen J, Sankkila L, Sugiyama N, et al. Secretion of active membrane type 1 matrix metalloproteinase (MMP‐14) into extracellular space in microvesicular exosomes. J Cell Biochem. 2008;105(5):1211–1218.
   PubMed Web of Science ®Google Scholar
• Weston CL, Glantz MJ, Connor JR. Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers Cns. 2011;8(1):14.
   PubMedGoogle Scholar
• Aguirre-Gamboa R, Gomez-Rueda H, Martínez-Ledesma E, et al. SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS One. 2013;8:e74250.
   PubMed Web of Science ®Google Scholar
• Kim D-K, Kang B, Kim OY, et al. EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles. 2013;2(1):20384.
   PubMedGoogle Scholar
• Pathan M, Fonseka P, Chitti SV, et al. Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res. 2019;47(D1):D516–D519.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzas EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2(1):20360.
   PubMedGoogle Scholar
• Lässer C, Alikhani VS, Ekström K, et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med. 2011;9(1):9.
   PubMedGoogle Scholar
• Chiasserini D, van Weering JR, Piersma SR, et al. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteomics. 2014;106:191–204.
   PubMed Web of Science ®Google Scholar
• Weber M, Zoubaa S, Schlieter M, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology. 2006;66(12):1899–1906.
   PubMed Web of Science ®Google Scholar
• Chittiboina P, Connor DE, Caldito G, et al. Occult tumors presenting with negative imaging: analysis of the literature: a review. JNS. 2012;116(6):1195–1203.
   Google Scholar
• Ricklefs FL, Maire CL, Reimer R, et al. Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours. J Extracell Vesicles. 2019;8(1):1588555–1588555.
   PubMed Web of Science ®Google Scholar
• Osti D, Del Bene M, Rappa G, et al. Clinical significance of extracellular vesicles in plasma from glioblastoma patients. Clin Cancer Res. 2019;25(1):266–276.
   PubMed Web of Science ®Google Scholar
• Chandran VI, Welinder C, Månsson A-S, et al. Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma. Clin Cancer Res. 2019;25(10):3115–3127.
   PubMed Web of Science ®Google Scholar
• Hallal S, Russell BP, Wei H, et al. Extracellular vesicles from neurosurgical aspirates identifies chaperonin containing TCP1 subunit 6A as a potential glioblastoma biomarker with prognostic significance. Proteomics. 2019;19(1–2):1800157.
   Web of Science ®Google Scholar
• Akers JC, Hua W, Li H, et al. A cerebrospinal fluid microRNA signature as biomarker for glioblastoma. Oncotarget. 2017;8(40):68769.
   PubMedGoogle Scholar
• Shao H, Chung J, Balaj L, et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med. 2012;18(12):1835.
   PubMed Web of Science ®Google Scholar
• Seehusen DA, Reeves MM, Fomin D. Cerebrospinal fluid analysis. Am Fam Physician. 2003;68(6):1103–1108.
   PubMed Web of Science ®Google Scholar
• Souweidane MM, Morgenstern PF, Christos PJ, et al. Intraoperative arachnoid and cerebrospinal fluid sampling in children with posterior fossa brain tumors. Neurosurgery. 2009;65(1):72–78.
   PubMed Web of Science ®Google Scholar
• Akers JC, Ramakrishnan V, Yang I, et al. Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid. CBM. 2016;17(2):125–132.
   Google Scholar
• Guo S-C, Tao S-C, Dawn H. Microfluidics-based on-a-chip systems for isolating and analysing extracellular vesicles. J Extracell Vesicles. 2018;7(1):1508271.
   PubMed Web of Science ®Google Scholar
• Chen C, Skog J, Hsu C-H, et al. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip. 2010;10(4):505–511.
   PubMed Web of Science ®Google Scholar
• Reátegui E, van der Vos KE, Lai CP, et al. Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Nat Commun. 2018;9(1):175.
   PubMedGoogle Scholar
• Shao H, Chung J, Lee K, et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat Commun. 2015;6(1):6999.
   PubMedGoogle Scholar
• Ko J, Hemphill MA, Gabrieli D, et al. Smartphone-enabled optofluidic exosome diagnostic for concussion recovery. Sci Rep. 2016;6(1):31215.
   PubMedGoogle Scholar
• Ebrahimkhani S, Vafaee F, Hallal S, et al. Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis. NPJ Precision Onc. 2018;2(1):28.
   PubMedGoogle Scholar
• Manda SV, Kataria Y, Tatireddy BR, et al. Exosomes as a biomarker platform for detecting epidermal growth factor receptor–positive high-grade gliomas. J Neurosurg. 2018;128(4):1091–1101.
   PubMed Web of Science ®Google Scholar
• Huang K, Fang C, Yi K, et al. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes. Theranostics. 2018;8(6):1540.
   PubMed Web of Science ®Google Scholar
• Figueroa JM, Skog J, Akers J, et al. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Neuro-Oncology. 2017;19(11):1494–1502.
   PubMed Web of Science ®Google Scholar
• Pinet S, Bessette B, Vedrenne N, et al. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells. Oncotarget. 2016;7(31):50349.
   PubMedGoogle Scholar
• Chen WW, Balaj L, Liau LM, et al. BEAMing and droplet digital PCR analysis of mutant IDH1 mRNA in glioma patient serum and cerebrospinal fluid extracellular vesicles. Mol Ther Nucleic Acids. 2013;2:e109.
   PubMedGoogle Scholar
• Noerholm M, Balaj L, Limperg T, et al. RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer. 2012;12(1):22.
   PubMedGoogle Scholar
• Padfield E, Ellis HP, Kurian KM. Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma. Front Oncol. 2015;5:5.
   PubMed Web of Science ®Google Scholar
• Kang J, Adamson C. Novel chemotherapeutics and other therapies for treating high-grade glioma. Expert Opin Investig Drugs. 2015;24(10):1361–1379.
   PubMed Web of Science ®Google Scholar
• Verhaak RGW, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98–110.
   PubMed Web of Science ®Google Scholar
• Akers JC, Ramakrishnan V, Kim R, et al. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One. 2013;8(10):e78115.
   PubMed Web of Science ®Google Scholar
• Schiera G, Di Liegro CM, Saladino P, et al. Oligodendroglioma cells synthesize the differentiation-specific linker histone H1 and release it into the extracellular environment through shed vesicles. Int J Oncol. 2013;43(6):1771–1776.
   PubMed Web of Science ®Google Scholar
• Kore RA, Abraham EC. Inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, upregulated in glioblastoma multiforme, raise the levels of CRYAB in exosomes secreted by U373 glioma cells. Biochem Biophys Res Commun. 2014;453(3):326–331.
   PubMed Web of Science ®Google Scholar
• Treps L, Edmond S, Harford-Wright E, et al. Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma. Oncogene. 2016;35(20):2615.
   PubMed Web of Science ®Google Scholar
• Haraszti RA, Didiot M-C, Sapp E, et al. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016;5(1):32570.
   PubMed Web of Science ®Google Scholar
• Yang J-K, Yang J-P, Tong J, et al. Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma. J Neurooncol. 2017;131(2):255–265.
   PubMed Web of Science ®Google Scholar
• Luhtala N, Aslanian A, Yates JR, et al. Secreted glioblastoma nanovesicles contain intracellular signaling proteins and active RAS incorporated in a farnesylation-dependent manner. J Biol Chem. 2017;292(2):611–628.
   PubMed Web of Science ®Google Scholar
• Lang H, Hu G, Chen Y, et al. Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3. Eur Rev Med Pharmacol Sci. 2017;21(5):959–972.
   PubMed Web of Science ®Google Scholar
• Figueroa J, Phillips LM, Shahar T, et al. Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR-1587. Cancer Res. 2017;77(21):5808–5819.
   PubMed Web of Science ®Google Scholar
• Nie J-H, Li H, Wu M-L, et al. Differential exosomic proteomic patterns and their influence in resveratrol sensitivities of glioblastoma cells. IJMS. 2019;20(1):191.
   Google Scholar
• Manterola L, Guruceaga E, Pérez-Larraya JG, et al. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro-Oncology. 2014;16(4):520–527.
   PubMed Web of Science ®Google Scholar
• García-Romero N, Carrión-Navarro J, Esteban-Rubio S, et al. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients. Oncotarget. 2017;8(1):1416.
   PubMedGoogle Scholar
• Lan F, Qing Q, Pan Q, et al. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma. Cell Oncol. 2018;41(1):25–33.
   Web of Science ®Google Scholar
• Cai Q, Zhu A, Gong L. Exosomes of glioma cells deliver miR-148a to promote proliferation and metastasis of glioblastoma via targeting CADM1. Bulletin du Cancer. 2018;105(7–8):643–651.
   PubMed Web of Science ®Google Scholar
• Tan SK, Pastori C, Penas C, et al. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme. Mol Cancer. 2018;17(1):74.
   PubMed Web of Science ®Google Scholar
• D'Agostino S, Salamone M, Di Liegro I, et al. Membrane vesicles shed by oligodendroglioma cells induce neuronal apoptosis. Int J Oncol. 2006;29:1075–1085.
   PubMed Web of Science ®Google Scholar
• Sharghi-Namini S, Tan E, Ong L-L, et al. Dll4-containing exosomes induce capillary sprout retraction in a 3D microenvironment. Sci Rep. 2015;4(1):4031.
   Google Scholar
• Taheri B, Soleimani M, Aval SF, et al. C6 glioma-derived microvesicles stimulate the proliferative and metastatic gene expression of normal astrocytes. Neurosci Lett. 2018;685:173–178.
   PubMed Web of Science ®Google Scholar
• Dai X, Liao K, Zhuang Z, et al. AHIF promotes glioblastoma progression and radioresistance via exosomes. Int J Oncol. 2019;54(1):261–270.
   PubMed Web of Science ®Google Scholar
• Zhao W, O'Malley Y, Wei S, et al. Irradiation of rat tubule epithelial cells alters the expression of gene products associated with the synthesis and degradation of extracellular matrix. Int J Radiat Biol. 2000;76(3):391–402.
   PubMed Web of Science ®Google Scholar